Newsfeeds - Spark Newswire

3 minute read

Chimerix Reports Data From Efficacy Analysis Of ONC201 In H3 K27M-mutant Glioma

Today, 6:22 AM

– Blinded Independent Central Review (BICR) of ONC201 Cohort Reported 20.0% Objective Response Rate (ORR) by RANO-HGG Criteria – – Compelling Durability of Responses with 11.2 Month Median

CMRX

32 minute read

Earnings Scheduled For November 4, 2021

By Benzinga Insights

Today, 6:22 AM

Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.

AAOI

7 minute read

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline

By Shanthi Rexaline

Today, 6:22 AM

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.

ADPT

1 minute read

12 Health Care Stocks Moving In Monday’s Pre-Market Session

By Benzinga Insights

Today, 6:22 AM

ADVM

7 minute read

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs

By Shanthi Rexaline

Today, 6:22 AM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14)

ACAD

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s After-Market Session

By Benzinga Insights

Today, 6:22 AM

Gainers

APYX

1 minute read

Earnings

Return on Capital Employed Insights for Chimerix

By Benzinga Insights

Today, 6:22 AM

After pulling data from Benzinga Pro it seems like during Q2, Chimerix's (NASDAQ:CMRX) reported sales totaled $391.00 thousand. Despite a 81.72% in earnings, the company posted a loss of $17.82 million.

CMRX

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 6:22 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

1 minute read

Chimerix Q2 EPS $(0.21) Misses $(0.19) Estimate, Sales $391.00K Miss $480.00K Estimate

By Benzinga Newsdesk

Today, 6:22 AM

Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 31.25 percent decrease over losses of $(0.16) per share from the

CMRX

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 6:22 AM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI